The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice

EMBO Journal

Volumn 19, Issue 23, 2000, Pages 6341-6350

  Bueno, Orlando F ^a   De Windt, Leon J ^a   Tymitz, Kevin M ^a   Witt, Sandra A ^a   Kimball, Thomas R ^a   Klevitsky, Raisa ^a   Hewett, Timothy E ^a   Jones, Steven P ^b   Lefer, David J ^b   Peng, Chang Fu ^c   Kitsis, Richard N ^c   Molkentin, Jeffery D ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Cardiac; Cardiomyopathy; Hypertrophy; MAPK; Transgenic

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; ENZYME ACTIVITY; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; ISOLATED HEART; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ADENOVIRIDAE; ANIMALIA; MUS MUSCULUS;

EID: 0034383952     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/19.23.6341     Document Type: Article

References (55)

1. Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2
2. Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats
3. Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53
4. The mitochondrial apoptotic pathway is activated by serum and glucose deprivation in cardiac myocytes
5. Endothelin-1, phorbol esters and phenylephrine stimulate MAP kinase activities in ventricular cardiomyocytes
6. Expression of protein kinase C β in the heart causes hypertrophy in adult mice and sudden death in neonates
7. Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy
8. Differential activation of protein kinase C isoforms by endothelin-1 and phenylephrine and subsequent stimulation of p42 and p44 mitogen-activated protein kinases in ventricular myocytes cultured from neonatal rat hearts
9. Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists, endothelin-1 and phenylephrine: A role in cardiac myocyte hypertrophy
10. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells
11. Transgenic Gαq overexpression induces cardiac contractile failure in mice
12. Local insulin-like growth factor I expression induces physiologic, then pathologic, cardiac hypertrophy in transgenic mice
13. Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: An apoptosis-independent model of dilated heart failure
14. Low- and high-level transgenic expression of β2-adrenergic receptors differentially affect cardiac hypertrophy and function in Gαq-overexpressing mice
15. β2-Adrenergic receptor overexpression exacerbates development of heart failure after aortic stenosis
16. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart
17. Progressive hypertrophy and heart failure in β1-adrenergic receptor transgenic mice
18. Organization and regulation of mitogen-activated protein kinase signaling pathways
19. The mitogen-activated protein kinase kinase MEK1 stimulates a pattern of gene expression typical of the hypertrophic phenotype in rat ventricular cardiomyocytes
20. Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach downregulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes
21. Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism
22. Transgenic remodeling of the regulatory myosin light chains in the mammalian heart
23. Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block
24. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress
25. Ultrasensitivity in the mitogen-activated protein kinase cascade
26. Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice
27. Adverse effects of chronic endogenous sympathetic drive induced by cardiac GS α overexpression
28. Ablation of the murine myosin heavy chain gene leads to dosage effects and functional deficits in the heart
29. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study
30. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy
31. Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling
32. Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways
33. Dissociation of p44 and p42 mitogen-activated protein kinase activation from receptor-induced hypertrophy in neonatal rat ventricular myocytes
34. The MEKK-JNK pathway is stimulated by odadrenergic receptor and ras activation and is associated with in vitro and in vivo Cardiac hypertrophy
35. Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice
36. Molecular characterization of the stretch-induced adaptation of cultured cardiac cells
37. Cardiac-specific overexpression of RhoA results in sinus and atrioventricular nodal dysfunction and contractile failure
38. Enhanced left ventricular performance in endurance trained older men
39. Inhibition of phosphatidylinositol 3-kinase activity by adenovirus-mediated gene transfer and its effect on insulin action
40. Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy
41. Extracellular signal-regulated protein kinase activation is required for the anti-hypertrophic effect of atrial natriurefic factor in neonatal rat ventricular myocytes
42. 'Stress-responsive' mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium
43. Altered focal adhesion regulation correlates with cardiomyopathy in mice expressing constitutively active racl
44. Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy
45. Mitogen-activated protein kinases mediate changes in gene expression, but not cytoskeletal organization associated with cardiac muscle cell hypertrophy
46. Increasing complexity of the Ras signaling pathway
47. Targeted overexpression of protein kinase C β2 iseform in myocardhim causes cardiomyopathy
48. + channel subunit in the mouse heart
49. Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human
50. Exercise-induced cardiac hypetrophy is associated with an increased myocardial compliance
51. Mechanical loading activates mitogen-activated protein kinase and S6 peptide kinase in cultured rat cardiac myocytes
52. A role for the p38 mitogen-activated protein kinase pathway in myocardial cell growth, sarcomeric organization and cardiac-specific gene expression
53. TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice
54. MAPK superfamily plays an important role in daunomycin-induced apoptosis of cardiac myocytes
55. Protein kinase C, but not tyrosine kinases or Ras, plays a critical role in angiotensin II-induced activation of Raf-1 kinase and extracelhilar signal-regulated protein kinases in cardiac myocytes